Fust Matthew K

DirectorNeumora Therapeutics, Inc. (NMRA) · full profile →Form 4 · filed May 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2025Grant(A)28K28K
May 28, 2025Disposed to issuer(D)86K0
May 28, 2025Disposed to issuer(D)28K0
May 28, 2025Grant(A)29K29K
May 28, 2025Grant(A)80K$080K
May 28, 2025Disposed to issuer(D)29K0
May 28, 2025Grant(A)86K86K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-079925) within minutes of acceptance. Every field above traces to the original document. Verify it directly: